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The molecular weight heterogeneities of Tbp1 and Tbp2 among a panel of 45 gonococcal isolates were
assessed. The tbpB genes from four of these strains were sequenced to characterize the Tbp2 sequence diversity
among gonococci. By expressing truncated versions of gonococcal Tbp2, we delimited the extent of Tbp2
necessary for transferrin binding in a Western blot.
The pathogenic Neisseria spp. are capable of utilizing iron
bound to human transferrin as their sole source of iron (24).
Two iron-repressed proteins that are thought to contribute to
transferrin receptor function have been identified in these bac-
terial pathogens (2, 5, 16, 20, 31). These proteins, transferrin-
binding proteins 1 and 2 (Tbp1 and Tbp2), are surface exposed
(6, 21) and thus potential vaccine candidates. Tbp1, which has
a molecular weight of approximately 100,000, has homology
with the family of integral outer membrane receptors (5, 20),
members of which are energized by a complex of proteins
including TonB, ExbB, and ExbD (17, 26). Mutants that do not
express Tbp1 cannot grow on transferrin as a sole iron source,
although they remain capable of some transferrin binding (5,
6). Tbp2 does not share identity with TonB-dependent outer
membrane receptors but is lipid modified (2). Gonococcal
Tbp22 mutants internalize iron from transferrin less efficiently
than do wild-type gonococci; however, the mutants remain
capable of growth on transferrin-bound iron (2). Tbp2s range
in molecular weight from 64,000 to 85,000 among clinical iso-
lates of Neisseria meningitidis (29) and have been shown to fall
into two classes based upon molecular weight and genomic
characteristics (29). Meningococcal Tbp2 is expressed during
infection, elicits bactericidal antibodies that block transferrin
binding, and elicits an antibody response in humans that is
reactive against multiple meningococcal strains (1, 7, 14, 21).
These observations have engendered optimism about the vac-
cine potential of meningococcal Tbp2. Because gonococcal
Tbp2 is similarly modified (2) and functionally related, we are
equally optimistic about the vaccine potential of this antigen,
although this communication represents the first characteriza-
tion of the antigenic heterogeneity of this protein among gono-
cocci.
Tbp1 and Tbp2 exhibit distinct transferrin-binding charac-
teristics as well as distinct physical characteristics. Tbp1 binds
to transferrin in affinity purification assays as well as in solid-
and liquid-phase transferrin-binding assays (6). Tbp1 also
binds transferrin when expressed alone by recombinant Esch-
erichia coli (4). Tbp1, however, does not maintain its trans-
ferrin-binding capability after boiling and sodium dodecyl sul-
fate-polyacrylamide gel electrophoresis; this characteristic is
specific to Tbp2 (2, 5). Tbp2 binds to transferrin in affinity
purifications but cannot be affinity purified from a Tbp12 mu-
tant in the presence of the detergent Sarkosyl (6, 16). This
observation has been interpreted as indicative of a physical
association between Tbp1 and Tbp2. Another transferrin-bind-
ing characteristic that is particular to Tbp2 is its ability to
discriminate between apo- and ferrated forms of transferrin in
both solid- and liquid-phase transferrin-binding assays (6).
Determination of the utility of Tbp2 as a gonococcal-vaccine
component requires assessment of the heterogeneity of this
protein in nature. This report represents the first characteriza-
tion of the extent of molecular weight, sequence, and antigenic
heterogeneity among Tbp2 proteins expressed by gonococci.
We have delimited a minimal domain, which extends through
the amino-terminal half of the protein, that is necessary for
transferrin binding to gonococcal Tbp2 in a Western blot. This
transferrin-binding domain is presumably important for the
function of this protein and, since it contains conserved se-
quences, represents a potential target for immunoprophylaxis.
Conserved and variable domains of gonococcal Tbp2s are dis-
cussed in the context of observations of functional constraints
made for Tbp2s from other pathogenic bacteria.
Molecular weight heterogeneity of gonococcal Tbp2s. We
obtained a set of 40 gonococcal strains from R. Brunham
(University of Manitoba, Winnipeg, Canada), which were iso-
lated over a period of 1 year from prostitutes in Nairobi. These
strains represent a broad range of serotypes and genotypes (3).
These strains were grown from frozen stocks on chemically
defined medium (CDM)-agarose plates (10) containing 2.5
mM transferrin (approximately 30% saturated with iron) as an
iron source. Whole-cell lysates of these iron-stressed gonococ-
cal strains were prepared by swabbing overnight growth from
CDM-transferrin plates grown at 378C in a 5% CO2 atmo-
sphere into CDM broth to a density of 100 Klett units, followed
by pelleting of the organisms and resuspension of the pellet in
Laemmli solubilizing buffer (19). b-Mercaptoethanol was
added to 5%, and the lysates were boiled for 2 min prior to
loading onto 7.5% polyacrylamide gels (19). The proteins were
transferred to nitrocellulose as described previously (6). Figure
1 shows a representative sample of the 45 gonococcal strains
tested for molecular weight heterogeneity of Tbp1 and Tbp2.
Tbp1 was detected (Fig. 1A) with a polyclonal antiserum raised
against Tbp1, an antiserum which has been described previ-
ously (5). Tbp2 was detected (Fig. 1B) with a horseradish
peroxidase (HRP)-human transferrin conjugate (Jackson Im-
munoResearch, West Grove, Pa.) by methods that have been
previously described (2, 6). Among the gonococcal strains
screened, Tbp1s ranged in molecular weight from 100,000 to
103,000, and gonococcal Tbp2s ranged from 78,000 to 86,000.
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Meningococcal Tbp1s and Tbp2s have been described as a
heterogeneous group of proteins that fall into two broad mo-
lecular weight classes, a high-molecular-weight class and a low-
molecular-weight class (29). We detected no evidence of the
low-molecular-weight class (approximately 63,000 to 65,000) of
Tbp2 among the gonococcal strains that we tested. An example
of the low-molecular-weight class of Tbp2 expressed by the
minority of meningococcal strains is that expressed by menin-
gococcal strain FAM20 (9) (Fig. 1, lane 14).
We assessed the localized antigenic heterogeneity of Tbp2
among a selected subset of the 45 gonococcal strains by react-
ing solubilized whole-cell proteins with an antiserum raised
against a 16-mer peptide predicted from the sequence of Tbp2
from gonococcal strain FA19. The sequence of this 16-mer
peptide is shown in Fig. 2. The antiserum was raised in mice
against a conjugate of the 16-mer peptide with Pierce’s Super-
Carrier (cationized bovine serum albumin) according to man-
ufacturer recommendations (Pierce, Rockford, Ill.). Mice were
immunized subcutaneously, initially with the peptide conjugate
in Freund’s complete adjuvant and twice subsequently with the
conjugate in Freund’s incomplete adjuvant. A Western blot
demonstrating the reactivity of this antiserum with Tbp2s from
13 gonococcal strains is shown in Fig. 1C. Although gonococcal
Tbp2 proteins reacted poorly with HRP-transferrin (Fig. 1B,
lanes 5 and 10), these proteins reacted strongly with the anti-
Tbp2 peptide serum (Fig. 1C, lanes 5 and 10). Surprisingly, two
gonococcal strains (FA1090 and UU1008) that are closely re-
lated to strain FA19 at the predicted-protein-sequence level
(see next section) did not express Tbp2 proteins to which the
antipeptide serum bound (Fig. 1C, lanes 2 [FA1090] and 3
[UU1008]). The Tbp2 expressed by meningococcal strain
FAM20, a representative of the low-molecular-weight class of
Tbp2s, also was not recognized by this antipeptide serum.
Sequence diversity among gonococcal and meningococcal
Tbp2s. We sequenced genes encoding Tbp2 (tbpB) from four
gonococcal strains among the panel tested for molecular
weight and antigenic heterogeneity. The tbpB genes were am-
plified by PCR from chromosomal DNA of the following gono-
coccal strains: FA6642 (a disseminated strain isolated from a
patient in North Carolina), FA1090 (obtained from Janne
Cannon, University of North Carolina), Pgh3-2 (obtained from
Lederle-Praxis Biologicals, Rochester, N.Y.), and UU1008
(obtained from Z. McGee, University of Utah). (For the po-
sitions of primers used to amplify the tbpB genes, see Fig. 4.)
The 59 amplimer sequence was GGGGTACCTCATTCTTTA
ATTGAATCGGGTTTGTTATG, and the 39 amplimer se-
quence was CGGATCCGGAACGATGCCGTCTGAAGCCT
TATTCTCG. PCR products were purified by agarose gel
electrophoresis followed by use of Magic PCR columns (Pro-
mega, Madison, Wis.). PCR products were then cloned into
the pCRII vector (Invitrogen, San Diego, Calif.), and their size
was confirmed by restriction digestion with EcoRI, which re-
leased the insert. The E. coli strain used for cloning was
DH5aMCR (Gibco BRL). Plasmid DNAwas purified by alkaline
lysis, followed by CsCl gradient ultracentrifugation (22). Puri-
fied DNA from five to six individual PCR clones was pooled to
provide a sequencing template preparation for dideoxy chain
termination sequencing with Sequenase (30). Both strands of
the pooled PCR templates were sequenced in both directions
with internal primers designed from the tbpB sequence of
strain FA19. In some cases, specific primers were synthesized
to sequence the tbpB genes from the other gonococcal strains.
Sequence analysis was performed with the University of Wis-
consin Genetics Computer Group software package (8).
An alignment of gonococcal Tbp2 sequences is shown in Fig.
2 along with the published sequences for several meningococ-
cal Tbp2 sequences, four of which are members of the high-
molecular-weight class (M982, M987, 6940, and S3032) (20,
23) and one of which represents the low-molecular-weight class
(B16B6) (20). The three meningococcal Tbp2 sequences most
recently added to the database (23) did not include the signal
sequences, which are omitted in Fig. 2. A diversity plot is
shown in Fig. 3, in which the number of different residues
found at any one position in the alignment is plotted against
the residue number. Such plots have been utilized to identify
conserved membrane-spanning stretches of residues in outer
membrane proteins (11). Several regions of relative conserva-
tion were detected by this method and are indicated in Fig. 2
and 3. These regions do not have the characteristics of mem-
brane-spanning segments of other outer membrane proteins,
including amphipathic stretches of residues predicted to form
b-strands (18). The cross-hatched bars in Fig. 2 highlight ap-
proximate extents of sequence conservation, which are identi-
fied as valleys in the diversity plot presented in Fig. 3. Con-
served domains 1 and 2 (Fig. 2) encompass residue positions at
which there are no more than three amino acid differences
among 10 aligned Tbp2 sequences. The end points of these
domains were determined by the first position in the alignment
at which more than three amino acids exist. Position 375, at
which there are four different amino acid residues, is included
in conserved domain 2 since it is flanked on either side by
identities. The amino terminus beyond the signal sequence is
conserved for approximately 60 residues. Conserved region 2,
encompassing positions 345 to 388 in the alignment, exhibits
61% identity among all 10 strains aligned. Of the 17 noniden-
tical residues, 9 are identical among all sequences in the align-
ment except for B16B6. Four shorter regions in the carboxy-
FIG. 1. Heterogeneity of Tbp1 and Tbp2 among gonococcal strains. Western
blots were probed with anti-Tbp1 serum (A), HRP-transferrin, which detects
Tbp2 (B), or an antiserum raised against a peptide of gonococcal Tbp2 (shown
in Fig. 2) (C). Lanes 1 to 5 contain whole-cell lysates of the gonococcal strains
FA19, FA1090, UU1008, Pgh3-2, and FA6642, respectively. Lanes 6 to 13 con-
tain lysates of gonococcal strains obtained from R. Brunham, as follows: 6, 4102;
7, 4121; 8, 4125; 9, 4136; 10, 4141; 11, 4146; 12, 4178; 13, 4196. Lane 14 contains
a whole-cell lysate from meningococcal strain FAM20. Approximate positions of
molecular mass markers are on the right. Blots were scanned with a Relisys 2412
scanner, and images were annotated with Adobe Photoshop software.
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terminal half can be identified (regions 3 to 6 in Fig. 2 and 3)
as containing at least 5 consecutive identities. Positions that
flank consecutive identities and that contain at least 9 of 10
identical residues are included in the conserved regions. The
first of these short regions (cross-hatched bar 3) contains a pair
of cysteine residues that are also conserved in the Tbp2 se-
quences from Actinobacillus pleuropneumoniae (12, 13) and
from Haemophilus influenzae (15). The boxed region of aligned
Tbp2s in Fig. 2 indicates the position of a conserved peptide
identified in A. pleuropneumoniae that bound to transferrin in
a solid-phase assay and thus may be important for ligand in-
teraction (32). Between these short homologous stretches are
quite divergent sequences. The amino-terminal half of Tbp2 is
particularly high in sequence diversity in that at some positions
as many as 8 of 10 sequences contain different amino acids.
This is somewhat in contrast to the observations of Rokbi et al.
(28), who concluded that the region of highest sequence diver-
sity among meningococcal strains resided in the carboxy-ter-
minal half of Tbp2 just downstream of the meningococcal
transferrin-binding domain. This so-called “hypervariable” do-
main does, however, contain the largest proportion of dele-
tions found in B16B6 Tbp2 when it is aligned with other Tbp2s
of the high-molecular-weight class.
Identification of a domain of gonococcal Tbp2 required for
transferrin binding. We utilized the ability of Tbp2 to bind
transferrin in a Western blot to delimit a minimal domain
necessary for transferrin binding. The identified domain is
necessary for interaction with transferrin under these in vitro
conditions, but this analysis does not preclude the possibility
that other binding domains that facilitate ligand interaction in
other assay formats exist within Tbp2. A fragment of the tbpB
gene from FA19 was cloned into the BamHI site of pBluescript
SKII(1) behind the inducible lac promoter (Stratagene, La
Jolla, Calif.). This clone (pUNCH750) expressed a portion of
Tbp2 translationally fused to the a-peptide of b-galactosidase
(Fig. 4). This fusion product retained transferrin-binding ca-
pability following denaturation and sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (Fig. 5B, lane 2). One ami-
no-terminal deletion product of this clone was constructed
such that the Tbp2 sequence was translationally fused to the
a-peptide. This clone was created by unidirectional exonucle-
ase III digestion (25) and was used previously for sequencing
FIG. 3. Diversity plot of five gonococcal and five meningococcal Tbp2 sequences. The number of different residues in the alignment shown in Fig. 2 is plotted as
a function of residue number. Regions of sequence conservation are highlighted by cross-hatched bars.
FIG. 2. Alignment of gonococcal and meningococcal Tbp2 sequences. Gonococcal sequences in the alignment are preceded by the letter g; meningococcal
sequences are preceded by the letter m. Residues identical in all 10 sequences are indicated by shading. Six regions of conservation are highlighted by cross-hatched
boxes numbered 1 to 6. The position of the FA19 Tbp2 peptide to which antiserum was raised is indicated by the double box. The single-boxed region indicates the
position of the conserved A. pleuropneumoniae Tbp2 peptide to which transferrin bound in a solid-phase assay (32). The transferrin-binding domain of Tbp2 from
gonococcal strain FA19 was determined to be between the 59 end point of pUNCH750 and the 39 end point of deletion construct C3. This domain is located within
the sequence flanked by the solid arrows. The end point of the first amino-terminal deletion that prevented transferrin binding to FA19 Tbp2 (N1) and the end point
of the first carboxy-terminal deletion that prevented transferrin binding to FA19 Tbp2 (C4) are indicated. The transferrin-binding domain of Tbp2 from meningococcal
strain M982 (34) is within the sequence flanked by the open arrows. The first amino- and carboxy-terminal deletions that prevent transferrin binding to M982 Tbp2
(34) are indicated by open triangles. The transferrin-binding domain of Tbp2 from meningococcal strain B16B6 (34) is within the sequence flanked by small solid circles.
The first amino- and carboxy-terminal deletions that prevent transferrin binding to B16B6 Tbp2 (34) are indicated by large solid circles. The carboxy-terminal end point
of the deletion in FA6819 is indicated by an open circle. Dots prior to the conserved cysteine residues indicate signal sequences not included in the published sequences.
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of the tbpB gene from strain FA19 (2). This deletion construct
was cloned in the E. coli strain BL21 because it lacks the
proteases OmpT and Lon (33). The amino-terminal end point
of Tbp2 expressed by this deletion clone (N1) is indicated in
Fig. 4. Carboxy-terminal deletions were also constructed by
restriction digestion, end repair, and ligation of the repaired
ends. Truncated versions of Tbp2 were expressed from these
constructs in DH5aMCR (Gibco BRL). End points of these
deletion constructs (C1 to C4) are also shown in Fig. 4 with
respect to the wild-type tbpB gene. The junctions of all of these
deletion constructs were sequenced to confirm that the ex-
pected deletion had occurred. Figure 5 shows that the trun-
cated Tbp2s expressed by the deletion clones reacted in West-
ern blots with the antipeptide serum (Fig. 5A) described above
or with HRP-transferrin (Fig. 5B). The amino-terminal dele-
tion (yielding construct N1) removed 171 amino acids from the
mature Tbp2 protein and rendered the protein incapable of
transferrin binding in a Western blot (Fig. 5B, lane 3). The first
three sequential carboxy-terminal deletion constructs of
pUNCH750 (C1, C2, and C3) were expressed as truncated
Tbps that remained capable of transferrin binding (Fig. 5B,
lanes 4 to 6), while deletion to the BbsI site (yielding C4)
prevented transferrin binding (Fig. 5B, lane 7). All of the
deletion constructs were expressed by E. coli since they reacted
with the antipeptide antiserum (Fig. 5A). The products of the
progressively greater carboxy-terminal deletions do not uni-
formly decrease in size, since some deletions result in fusion
with the a-peptide downstream of the deletion site and others
do not. For example, deletion to the AccI site of tbpB (C3 in
Fig. 4 and lane 6 in Fig. 5) resulted in a protein with the
predicted molecular mass of 48 kDa, which was not the result
of fusion with the a-peptide downstream of the fusion junction.
The next greater deletion, to the BbsI site of tbpB (C4 in Fig.
4 and lane 7 in Fig. 5), resulted in a protein with the predicted
molecular mass of 55 kDa, which was the result of fusion of
Tbp2 with the a-peptide downstream of the fusion junction.
The presence of multiple Tbp2-specific bands detected with
the antipeptide serum might be the result of proteolytic cleav-
age of fusion proteins in E. coli since expression of the amino-
terminal deletion construct (N1) in a protease-deficient strain,
BL21, resulted in fewer Tbp2-specific products (Fig. 5, lane 3).
Alternatively, the presence of multiple bands might be the
result of incomplete denaturation of gonococcal Tbp2, a phe-
nomenon consistent with the observation that transferrin bind-
ing by meningococcal Tbp2 requires the presence of a stable,
heat-resistant, highly structured domain (34). Also consistent
with the presence of a folded, transferrin-binding domain is the
observation that all of the deletion species capable of trans-
ferrin binding migrate at an apparent molecular mass larger
than that predicted by their protein sequence. The minimal
extent of a transferrin-binding domain of Tbp2 from gonococ-
FIG. 4. Schematic diagram of amino- and carboxy-terminal deletions of gonococcal Tbp2. The tbpB gene, which encodes Tbp2, is schematically represented at the
top. The start of the open reading frame that encodes Tbp2 is indicated by the arrow; the stop codon is indicated by the asterisk. The approximate positions of the
amplimers used in PCR to amplify the tbpB gene for sequencing are indicated by partial arrows. The extent of gonococcal insert DNA in pUNCH750 is represented
below tbpB, flanked by Sau3AI sites (S). The extent of gonococcal DNA remaining in the amino-terminal deletion construct (N1) and in the carboxy-terminal deletion
constructs (C1 to C4) is indicated. The extent of the tbpB gene remaining in the chromosome of FA6819 after deletion to the NheI site (N) is indicated at the bottom.
Restriction endonuclease sites: B, BbsI; Ac, AccI; Bs, BspMI; A, AgeI; H, HincII; D, DraI.
FIG. 5. Transferrin-binding activity of amino- and carboxy-terminal deletions
of gonococcal Tbp2. (A) Western blot probed with an antiserum raised against
a peptide of gonococcal Tbp2; (B) Western blot probed with HRP-transferrin to
detect transferrin binding to Tbp2. Lane 1 contains a whole-cell lysate of gono-
coccal strain FA19, representing the wild-type size of Tbp2. Lanes 2 to 7 contain
whole-cell lysates of E. coli strains expressing portions of Tbp2 from the follow-
ing deletion constructs: 2, pUNCH750; 3, N1; 4, C1; 5, C2; 6, C3; 7, C4. Lane 8
contains a whole-cell lysate of gonococcal strain FA6819, which expresses a
truncated version of Tbp2. Approximate positions of molecular mass markers are
on the right. Blots were scanned with a Relisys 2412 scanner, and images were
annotated with Adobe Photoshop software.
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cal strain FA19 is indicated in Fig. 2. Deletion of 163 amino
acids from the amino terminus and 93 amino acids from the
carboxy terminus of this domain prevented transferrin binding
in a Western blot.
A deletion mutant of tbpB was previously constructed
(FA6819 [2]) for analysis of the phenotype of a Tbp22-Tbp11
gonococcal mutant. We determined that although this gono-
coccal mutant made a stable peptide of Tbp2 (Fig. 5A, lane 8),
this peptide no longer bound transferrin (Fig. 5B, lane 8). The
limits of the truncated Tbp2 synthesized by this mutant gono-
coccal strain are indicated in Fig. 4. Since this strain and a
complete Tbp2 deletion strain react identically in transferrin-
binding assays and iron uptake studies (6), we conclude that
either this truncated peptide expressed by FA6819 is not pro-
cessed to the gonococcal cell surface or this peptide does not
contribute to transferrin binding and iron uptake from trans-
ferrin when expressed by the gonococcus.
Conclusions. This analysis of molecular weight and se-
quence heterogeneity of Tbp2s among gonococci suggests that
the gonococcal proteins are less diverse as a group than are the
Tbp2 proteins from meningococcal strains. Gonococcal Tbp2s
fell within a narrow molecular weight range, and we found no
evidence, among the 45 strains examined, of a low-molecular-
weight class of gonococcal Tbp2 proteins analogous to the class
of meningococcal Tbp2s with molecular masses of 65 to 68 kDa
(29). Pairwise comparisons between predicted Tbp2 sequences
of gonococcal strains generated 69 to 84% identity. Pairwise
comparisons between the sequenced example of the low-mo-
lecular-weight class of meningococcal Tbp2 (from B16B6) and
the other Tbp2s of the high-molecular-weight class generated
only 46 to 49% identity. Comparisons between gonococcal and
meningococcal Tbp2 sequences of the high-molecular-weight
class generated identity scores ranging from 64 to 75%.
The diversity plot shown in Fig. 3 points out several regions
of conservation that might be important for Tbp2 function,
that is, for transferrin binding or for stability and assembly of
Tbp2 on the bacterial cell surface. Conserved domain 1 con-
tains the first 53 residues of the mature gonococcal Tbp2 pro-
tein. Deletion of eight amino acids of the amino terminus of
the mature protein did not affect transferrin binding in a West-
ern blot (Fig. 2); however, this conserved region is probably
important for assembly or export of mature Tbp2 to the outer
membrane, as is the case for other lipid-modified proteins (27).
Deletion of the conserved YGFA residues within domain 1
from meningococcal Tbp2 prevented transferrin binding in a
ligand-binding Western blot (34), thus implicating the region
containing these residues as important for ligand interaction.
Deletion of conserved domain 2 from the carboxy terminus
prevented transferrin binding to Tbp2 constructs in a Western
blot, which similarly implicates this region in ligand interac-
tion. These regions are not necessarily in direct contact with
transferrin but might be required for maintenance of a con-
formation that facilitates transferrin binding to Tbp2, as has
been suggested for meningococcal Tbp2s (34). The short con-
served domains numbered 3 to 6 in the carboxy-terminal half
of the protein were not required to reconstitute transferrin
binding to Tbp2 in a Western blot since in all of the minimal
transferrin-binding constructs (Fig. 2) these regions were de-
leted. Region 3 contains a pair of cysteine residues that are
also present in the same relative location in Tbp2s from A.
pleuropneumoniae and in H. influenzae. These residues, while
clearly not critical for transferrin interaction, might be neces-
sary for structure maintenance at the cell surface. The impor-
tance of the other conserved domains remains unclear but will
be addressed by site-specific mutagenesis followed by func-
tional assays for ligand binding, assembly, and export.
Nucleotide sequence accession numbers.Accession numbers
for the gonococcal tbpB genes presented in this report are as
follows: U65219 for tbpB from FA1090, U65220 for tbpB from
FA6642, U65221 for tbpB from Pgh3-2, and U65222 for tbpB
from UU1008.
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